Alembic Limited Reports Q2 Revenue of ₹302.5 Million Against ₹558.6 Million YoY

Market snapshot: Alembic Limited has reported its Q2 revenue from operations at ₹30.25 crore (₹302.5 million), representing a significant drop compared to ₹55.86 crore (₹558.6 million) recorded in the corresponding quarter of the previous year.

Data Snapshot

• Q2 revenue from operations stood at ₹30.25 crore (₹302.5 million) compared to ₹55.86 crore (₹558.6 million) in the prior-year quarter.
• The Q2 topline reflects a year-on-year revenue contraction of approximately 45.85% YoY (derived: ₹30.25 crore vs ₹55.86 crore).

What's Changed

• Alembic Limited Q2 revenue contracted by ~45.85% YoY to ₹30.25 crore from ₹55.86 crore reported in the matching period of the previous year.

Key Takeaways

• Q2 topline dropped to ₹30.25 crore, registering a significant year-on-year decline.
• The revenue decrease of ~45.85% YoY highlights quarterly operational headwinds across active business segments.

SAHI Perspective

The sharp drop in Q2 revenue to ₹30.25 crore indicates potential cyclical or project execution timing impacts in Alembic Limited's operations. Investors will need to closely assess operating cost alignment and segment disclosures to evaluate margin resilience.

Market Implications

Topline contraction of this magnitude may weigh on near-term market sentiment around Alembic Limited until clear signals of quarterly recovery or sequential margin improvement emerge.

Trading Signals

Market Bias: Bearish

The ~45.85% YoY revenue decline to ₹30.25 crore from ₹55.86 crore points to top-line contraction and near-term growth resistance.

Underweight: Active Pharmaceutical Ingredients & Real Estate Operations

Trigger Factors:

• Sequential quarterly revenue recovery in upcoming reporting periods
• Operational cost management and margin trajectory updates

Time Horizon: Near-term (0-3 months)

Industry Context

Companies with dual exposure to chemical/API manufacturing and real estate construction often experience lumpiness in quarterly revenue recognition depending on project execution schedules and demand cycles.

Key Risks to Watch

• Continued weakness or volatility in quarterly operational revenue
• Input cost inflation affecting profit margins during top-line slowdowns

Recent Developments

No verified developments in this window

Closing Insight

Monitoring management updates regarding project completion schedules and operational revenue drivers will be crucial for assessing medium-term recovery prospects.

High Performance Trading with SAHI.